Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated through increased PR-mediated signaling, leading to an inhibition of luteinizing hormone release from the pituitary gland, via a negative feedback mechanism, and, eventually, an inhibition of estrogen released from the ovaries.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約 35 days | ¥ 18,000 |
5 mg | 約 35 days | ¥ 53,500 |
10 mg | 約 35 days | ¥ 88,000 |
説明 | Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated through increased PR-mediated signaling, leading to an inhibition of luteinizing hormone release from the pituitary gland, via a negative feedback mechanism, and, eventually, an inhibition of estrogen released from the ovaries. |
別名 | XBIO-101, XBIO 101, Cycloferon, Sodium Cridanimod, Cridanimod Na, XBIO101 |
分子量 | 276.24 |
分子式 | C15H11NNaO3 |
CAS No. | 58880-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cridanimod sodium 58880-43-6 XBIO-101 XBIO 101 Cycloferon Sodium Cridanimod Cridanimod Na XBIO101 Inhibitor inhibitor inhibit